Off-Patent Generic Medicines vs. Off-Patent Brand Medicines for Six Reference Drugs: A Retrospective Claims Data Study from Five Local Healthcare Units in the Lombardy Region of Italy-Reference-Cited by-同舟云学术

Off-Patent Generic Medicines vs. Off-Patent Brand Medicines for Six Reference Drugs: A Retrospective Claims Data Study from Five Local Healthcare Units in the Lombardy Region of Italy

Published:2013-12-18 Issue:12 Volume:8 Page:e82990
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Colombo Giorgio L.,Agabiti-Rosei Enrico,Margonato Alberto,Mencacci Claudio,Montecucco Carlo Maurizio,Trevisan Roberto

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference34 articles.

1. Comparing generic and innovator drugs: a review of 12 years of bioequivalence data from the United States Food and Drug Administration. LX, Woodcock J. Ann Pharmacother;BM Davit;Oct,2009

2. Impact of European pharmaceutical price regulation on generic price competition: a review;J Puig-Junoy;Pharmacoeconomics,2010

3. Generic medicine pricing in Europe: current issues and future perspective;S Simoens;J Med Econ,2008

4. AIFA Italian Medicines Agency - Gruppo di lavoro OSMED, L'uso dei farmaci in Italia, Rapporto OsMed (gennaio-settembre 2012), Dicember 2012. Available: http://www.agenziafarmaco.gov.it/it/content/luso-dei-farmaci-italia-rapporto-osmed-gennaio-settembre-2012. Accessed 28 February 2013.

5. AIFA Italian Medicines Agency, Decreto legge 31 maggio 2010, n. 78 in Supplemento ordinario n. 114/L alla Gazzetta Ufficiale serie generale - n. 125 del 31 maggio 2010; Art. 11, comma 7b: Controllo della spesa sanitaria. Available http://www.dps.tesoro.it/documentazione/uval/DL_78_2010.pdf. Accessed 30 October 2013

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prescribing Behavior of General Practitioners for Generic Drugs;International Journal of Environmental Research and Public Health;2020-08-14

2. Are Generic Drugs Used in Cardiology as Effective and Safe as their Brand-name Counterparts? A Systematic Review and Meta-analysis;Drugs;2020-04-11

3. Nitrogen Mustards as Alkylating Agents: A Review on Chemistry, Mechanism of Action and Current USFDA Status of Drugs;Anti-Cancer Agents in Medicinal Chemistry;2019-10-23

4. The Role of European Healthcare Databases for Post-Marketing Drug Effectiveness, Safety and Value Evaluation: Where Does Italy Stand?;Drug Safety;2018-09-29

5. Methodological Considerations for Comparison of Brand Versus Generic Versus Authorized Generic Adverse Event Reports in the US Food and Drug Administration Adverse Event Reporting System (FAERS);Clinical Drug Investigation;2017-09-20